Tag: book

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Acquisition Corp (Nasdaq: FWACU, the “Company”) announced today that it closed its initial public offering (“IPO”) of 8,625,000 units at an offering price of $10.00 per unit, including the 1,125,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, resulting in aggregate gross proceeds of $86,250,000, before deducting underwriting discounts and estimated offering expenses.

EXCLUSIVE INTERVIEWIn a historic and extensive interview lasting over an hour with journalist Ismael Cala, the President of the Argentine Republic strips away his...

EXCLUSIVE INTERVIEWIn a historic and extensive interview lasting over an hour with journalist Ismael Cala, the President of the Argentine Republic strips away his...

ADMA Biologics Investors Sue for Recovery in Securities Fraud Class Action after 29% Stock Drop – Investors Notified to Contact BFA Law

Reference is made to the stock exchange notice published by Voim ASA (the "Company") on 24 June 2026 regarding the completion of the annual general meeting of the Company and that all items on the agenda had been resolved in accordance with the respective proposals.

TEMPE, Ariz., June 25, 2026 /PRNewswire/ -- Doctors of Behavioral Health are helping shape the future of integrated care with the publication of Integrated...

The Canadian Ethnic Media Association Celebrates its47th Annual Awards for Journalistic ExcellenceContinuous Webcast Launch:  Friday, June 26, 2026UPDATE:    Broadcast Air-DatesTORONTO, June 25, 2026 /CNW/...

Sandbox VR brings the 'best virtual reality experience on the planet' to Downtown Ann ArborANN ARBOR, Mich., June 25, 2026 /PRNewswire/ -- Sandbox VR,...

NEW YORK, June 25, 2026 /PRNewswire/ -- Summer is officially here, and the season's best plans are moving poolside. ResortPass, the leading platform for booking...

BERLIN, June 25, 2026 /PRNewswire/ -- Fast-scaling email signature provider Crossware announced that its European expansion is gathering significant momentum on the eve of GITEX AI...

DALLAS, June 24, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 32,500,001 shares of its common stock at a price to the public of $6.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 833,333 shares of its common stock at an offering price of $5.999 per pre-funded warrant, in each case before underwriting discounts and commissions. All of the securities are being offered by Taysha. In addition, Taysha has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering to Taysha are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about June 26, 2026, subject to customary closing conditions.

RALEIGH, N.C., June 24, 2026 /PRNewswire/ -- Cardinal Infrastructure Group, Inc. (the "Company" or "Cardinal") (Nasdaq: CDNL) today announced the pricing of an upsized...